CRISPR

CRISPR1-minar1

ID
ZDB-CRISPR-200210-2
Name
CRISPR1-minar1
Previous Names
  • CRISPR1-si:cabz01029535.1
Target
Sequence
5' - GGTATTGAGAAAAGAGAGGTTGG - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
zf3113 minar1
Expression
Gene expression in Wild Types + CRISPR1-minar1
No data available
Phenotype
Phenotype resulting from CRISPR1-minar1
No data available
Phenotype of all Fish created by or utilizing CRISPR1-minar1
Phenotype Fish Conditions Figures
whole organism ab8-rps6 labeling amount, ameliorated minar1zf3113/zf3113 chemical treatment by environment: pentetrazol, chemical treatment by environment: sirolimus Fig. 7 with image from Wang et al., 2021
spinal cord interneuron fosab expression amount, ameliorated minar1zf3113/zf3113 chemical treatment by environment: sirolimus Fig. 5 with image from Wang et al., 2021
CiD calcium ion transport increased frequency, abnormal minar1zf3113/zf3113 standard conditions Fig. 3 with image from Wang et al., 2021
spinal cord fosab expression amount, ameliorated minar1zf3113/zf3113 chemical treatment by environment: pentetrazol, chemical treatment by environment: sirolimus Fig. 7 with image from Wang et al., 2021
swimming behavior increased rate of occurrence, ameliorated minar1zf3113/zf3113 chemical treatment by environment: pentetrazol, chemical treatment by environment: sirolimus Fig. 7 with image from Wang et al., 2021
brain fosab expression increased amount, abnormal minar1zf3113/zf3113 chemical treatment by environment: pentetrazol Fig. 6 with image,  Fig. 7 with image from Wang et al., 2021
swimming behavior sporadic, abnormal minar1zf3113/zf3113 standard conditions Fig. 1 with image,  Fig. 5 with image from Wang et al., 2021
whole organism fosab expression amount, ameliorated minar1zf3113/zf3113 chemical treatment by environment: sirolimus Fig. 5 with image from Wang et al., 2021
brain fosab expression amount, ameliorated minar1zf3113/zf3113 chemical treatment by environment: pentetrazol, chemical treatment by environment: sirolimus Fig. 7 with image from Wang et al., 2021
brain fosab expression increased amount, abnormal minar1zf3113/zf3113 standard conditions Fig. 6 with image from Wang et al., 2021
spinal cord fosab expression increased amount, abnormal minar1zf3113/zf3113 chemical treatment by environment: pentetrazol Fig. 6 with image from Wang et al., 2021
whole organism fosab expression increased amount, abnormal minar1zf3113/zf3113 standard conditions Fig. 2 with image,  Fig. 5 with image from Wang et al., 2021
swimming behavior increased rate of occurrence, exacerbated minar1zf3113/zf3113 chemical treatment by environment: pentetrazol Fig. 6 with image from Wang et al., 2021
swimming behavior increased rate of occurrence, abnormal minar1zf3113/zf3113 chemical treatment by environment: pentetrazol Fig. 7 with image from Wang et al., 2021
whole organism ab8-rps6 labeling increased amount, abnormal minar1zf3113/zf3113 chemical treatment by environment: pentetrazol Fig. 6 with image,  Fig. 7 with image from Wang et al., 2021
whole organism fosab expression increased amount, abnormal minar1zf3113/zf3113 chemical treatment by environment: pentetrazol Fig. 7 with image from Wang et al., 2021
swimming behavior normal frequency, abnormal minar1zf3113/zf3113 standard conditions Fig. 6 with image from Wang et al., 2021
spinal cord fosab expression increased amount, abnormal minar1zf3113/zf3113 standard conditions Fig. 2 with image,  Fig. 6 with image from Wang et al., 2021
whole organism ab8-rps6 labeling amount, ameliorated minar1zf3113/zf3113 chemical treatment by environment: sirolimus Fig. 5 with image from Wang et al., 2021
spinal cord interneuron fosab expression increased distribution, abnormal minar1zf3113/zf3113 standard conditions Fig. 5 with image from Wang et al., 2021
whole organism fosab expression amount, ameliorated minar1zf3113/zf3113 chemical treatment by environment: pentetrazol, chemical treatment by environment: sirolimus Fig. 7 with image from Wang et al., 2021
swimming behavior sporadic, ameliorated minar1zf3113/zf3113 chemical treatment by environment: sirolimus Fig. 5 with image from Wang et al., 2021
whole organism ab8-rps6 labeling increased amount, abnormal minar1zf3113/zf3113 standard conditions Fig. 5 with image from Wang et al., 2021
brain ab8-rps6 labeling increased amount, abnormal minar1zf3113/zf3113 (AB) food availability, fasting Fig. 7 with image from Zhang et al., 2018
TOR signaling increased occurrence, abnormal minar1zf3113/zf3113 (AB) food availability, fasting Fig. 7 with image from Zhang et al., 2018
TOR signaling increased occurrence, abnormal minar1zf3113/zf3113 (AB) standard conditions Fig. 7 with image from Zhang et al., 2018
fear response process characteristic, abnormal minar1zf3113/zf3113 (AB) control Fig. S7 from Zhang et al., 2018
head ab6-rps6k labeling increased amount, abnormal minar1zf3113/zf3113 (AB) standard conditions Fig. 7 with image from Zhang et al., 2018
brain ab6-rps6k labeling increased amount, abnormal minar1zf3113/zf3113 (AB) fasting Fig. 7 with image from Zhang et al., 2018
TOR signaling increased occurrence, abnormal minar1zf3113/zf3113 (AB) fasting Fig. 7 with image from Zhang et al., 2018
behavior process characteristic, abnormal minar1zf3113/zf3113 (AB) control Fig. S7 from Zhang et al., 2018
brain ab8-rps6 labeling increased amount, abnormal minar1zf3113/zf3113 (AB) fasting Fig. 7 with image from Zhang et al., 2018
spinal cord interneuron ab8-rps6 labeling increased distribution, abnormal minar1zf3113/zf3113; nkuasgfp1aTg/nkuasgfp1aTg; zf3111Et/zf3111Et standard conditions Fig. 4 with image from Wang et al., 2021
Citations